Pharmacyclics LLC - Company Profile

Powered by

All the sales intelligence you need on Pharmacyclics LLC in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Pharmacyclics LLC fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Pharmacyclics LLC.

Back to companies

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Pharmacyclics LLC (Pharmacyclics), a subsidiary of AbbVie Inc, is a biopharmaceutical company which focuses on the development and commercialization of small-molecule medicines for the treatment of cancer and immune-mediated diseases. The company’s marketed product includes Imbruvica is an once-daily, first-in-class bruton's tyrosine kinase (BTK) inhibitor developed for the treatment of patients with chronic lymphocytic leukemia, waldenstrom's macroglobulinemia, mantle cell lymphoma, marginal zone lymphoma and chronic graft-versus-host disease. Its products candidate in clinical development includes Imbruvica BTK inhibitor intended for the treatment of chronic lymphocytic leukemia, small lymphocytic lymphoma, mantle cell lymphoma, diffuse large b-cell lymphoma, follicular lymphoma, graft versus host disease, mature B-cell non-hodgkin lymphomas and solid tumors, among others. Pharmacyclics is headquartered in Sunnyvale, California, the US..

Gain a 360-degree view of Pharmacyclics LLC and make more informed decisions for your business Gain a 360-degree view of Pharmacyclics LLC and make more informed decisions for your business Learn more
Headquarters United States of America

Address 999 East Arques Avenue, Sunnyvale, California, 94085


Telephone 1 408 2153000

Industry Pharmaceuticals and Healthcare

   

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Pharmacyclics LLC premium industry data and analytics

140+

Clinical Trials

Determine Pharmacyclics LLC go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

50+

Catalyst Calendar

Proactively evaluate Pharmacyclics LLC’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

50+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

11+

Pipeline Drugs

Identify which of Pharmacyclics LLC’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Pharmacyclics LLC’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Marketed Pharmacyclics
Imbruvica (ibrutinib): Imbruvica
Chronic Lymphocytic Leukemia
XYZ
XYZ
XYZ
Understand Pharmacyclics LLC portfolio and identify potential areas for collaboration Understand Pharmacyclics LLC portfolio and identify potential areas for collaboration Learn more
Image for loader

Competitor Comparison

Key Parameters Pharmacyclics LLC Pharming Group NV CTI BioPharma Corp (Inactive) Ambrilia Biopharma Inc Aphios Corp
Headquarters United States of America Netherlands United States of America Canada United States of America
City Sunnyvale Leiden Waltham Montreal North Reading
State/Province California Zuid-Holland Massachusetts Quebec Massachusetts
No. of Employees - 407 128 - -
Entity Type Private Public Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Executives
Name Position Board Since Age
Angelina Wong Associate Director - Drug Product, Process and Equipment Engineering Senior Management - -
Stefan Geldmeyer Head - Finance and Infrastructure Senior Management 2016 -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Pharmacyclics LLC key executives to enhance your sales strategy Gain insight into Pharmacyclics LLC key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?